Clinical Trials Logo

Clinical Trial Summary

The goal of this clinical trial is to assess whether wheeze as assessed by a commercially available wheeze monitor is comparable to lung function as measured during a spirometry test. The main questions it aims to answer are whether measures of airflow obstruction (FEV1, FEV1/FVC, PEF) correlate with wheeze score (Tw/Ttot%). Participants consenting to take part will undergo wheeze measurement prior to and during a spirometry test and will be asked to complete a series of symptom questionnaires.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06039943
Study type Interventional
Source University Hospital Birmingham
Contact Brendan Cooper, PhD
Phone 01213713890
Email Brendan.Cooper@uhb.nhs.uk
Status Recruiting
Phase N/A
Start date March 13, 2023
Completion date August 1, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT06099145 - Clinical and Medico-economic Validation of the HEPHAI Solution. N/A
Completed NCT06417931 - Medication Adherence and Use of Inhaler Devices in Patients With Asthma or COPD N/A
Completed NCT05764343 - The Effect of Immediate Smoking Cessation Interventions for Smokers With Chronic Airway Diseases N/A
Active, not recruiting NCT05006521 - Single and Multiple Ascending Dose Study of KN-002 Phase 1
Recruiting NCT05299385 - The Study for Evaluating the Clinical Effectiveness and Safety of Respiratory Rehabilitation Software 'Redpill Breath'(COPD, Asthma, Lung Cancer, Etc.) Phase 3
Active, not recruiting NCT04341701 - Phenotype Identification Based on Multimodal MRI Analysis of Patients With Bronchial Obstructive Diseases N/A
Recruiting NCT04233190 - A Multicenter, Randomized, Parallel, Two-Period, Non-Inferiority Study of EurofarmavsAlenia in Asthma and COPD Treatment Phase 3